收稿日期: 2026-07-03
修回日期: 2026-08-17
网络出版日期: 2026-09-03
基金资助
国家自然科学基金(编号:U25A20134, 32500514)资助 [supported by the National Natural Science Foundation of China (Nos.U25A20134, 32500514)]
Multi-omics applications in mitochondrial disease research and clinical management
2. Institute of Genetics, Zhejiang University,Hangzhou 310058, China
Received date: 2026-07-03
Revised date: 2026-08-17
Online published: 2026-09-03
周天未, 艾成, 管敏鑫 . 多组学技术在线粒体疾病的基础研究和临床诊疗中的应用[J]. 遗传, 0 : 0 . DOI: 10.16288/j.yczz.26-109
Mitochondrial diseases are a group of highly heterogeneous genetic disorders that affect any organ at any age, caused by mutations in nuclear and mitochondrial genes, characterized by complex clinical manifestations and diagnostic challenges. Multi-omics technologies have emerged as essential tools for deciphering the molecular basis of these diseases and improving clinical outcomes. This review summarizes the research progress of multi-omics approaches—including genomics, transcriptomics, proteomics, metabolomics, and single-cell sequencing—in resolving genetic and phenotypic heterogeneity and elucidating cell- and tissue-specific mechanisms of representative mitochondrial diseases. We aim to provide a reference and framework for the translation of multi-omics technologies from basic research to clinical application within the field of mitochondrial medicine.
/
| 〈 |
|
〉 |